GlassScriptPhysician profile
Brittany R Simpson
NPI 1063877850
$7,997.13
in general payments reported to CMS, 2019-2025
52 companies · $1,840 in 2025
The $1,840 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $768 · 2022: $1,970 · 2023: $1,726 · 2024: $1,693 · 2025: $1,840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,200 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,199.55 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,271.97 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $851.11 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Xeris Pharmaceuticals, INC. | $733.42 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Dexcom, INC. | $602.78 | 2021-2025 | Dexcom G6 Transmitter |
| Insulet Corporation | $576.30 | 2022-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $563.43 | 2022-2025 | |
| Corcept Therapeutics | $356.97 | 2022-2025 | Korlym |
| Mannkind Corporation | $352.08 | 2022-2025 | Afrezza |
| Novartis Pharmaceuticals Corporation | $325.29 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $249.24 | 2021-2024 | |
| Amgen INC. | $239.99 | 2021-2025 | Tepezza, Repatha, Repatha |
| Radius Health, INC. | $162.79 | 2023-2025 | Tymlos |
| Amphastar Pharmaceuticals, INC. | $129.06 | 2024-2025 | |
| Cequr Corporation | $128.30 | 2024-2025 | Cequr Simplicity |
| Takeda Pharmaceuticals U.S.A., INC. | $83.46 | 2021 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.